Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Treatment-Resistant RBD
NCT04006925Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate in REM sleep behavior disorder (RBD), sponsored by Stanford University. Started Sep 2019; status: completed.
02
Drugs
sodium oxybate
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT04006925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006925.